Gilead Sciences rectal gel can prevent HIV infection: New study
Study findings demonstrated that the gel, when applied to the vagina in previous trials, reduced HIV infection by 34% compared with placebo, which urged researchers to find out
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.